The effects of haloperidol on cocaine-induced conditioned taste aversions

Physiology and Behavior

Volumn 105, Issue 5, 2012, Pages 1161-1167

  Serafine, Katherine M ^a   Briscione, Maria A ^a   Riley, Anthony L ^a  

^a AMERICAN UNIVERSITY   (United States)

Author keywords

Antagonism; Cocaine; CTA; Dopamine; Haloperidol; Mechanism

Indexed keywords

COCAINE; DOPAMINE; HALOPERIDOL;

ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TASTE AVERSION; TREATMENT RESPONSE;

ANALYSIS OF VARIANCE; ANIMALS; ASSOCIATION LEARNING; AVOIDANCE LEARNING; COCAINE; CONDITIONING, CLASSICAL; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HALOPERIDOL; MALE; RATS; RATS, SPRAGUE-DAWLEY; TASTE;

EID: 84855757886     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.12.014     Document Type: Article

References (73)

1. Nomikos G.G., Spyraki C. Cocaine-induced place conditioning: importance of route of administration and other procedural variables. Psychopharmacology (Berl) 1988, 94:119-125.
2. Kosten T.A., Miserendino M.J., Haile C.N., DeCaprio J.L., Jatlow P.I., Nestler E.J. Acquisition and maintenance of intravenous cocaine self-administration in Lewis and Fischer inbred rat strains. Brain Res 1997, 778:418-429.
3. Wise R.A., Bauco P., Carlezon W.A., Trojniar W. Self-stimulation and drug reward mechanisms. Ann N Y Acad Sci 1992, 654:192-198.
4. Ettenberg A. Opponent process properties of self-administered cocaine. Neurosci Biobehav Rev 2004, 27:721-728.
5. Ferrari C.M., O'Connor D.A., Riley A.L. Cocaine-induced taste aversions: effect of route of administration. Pharmacol Biochem Behav 1991, 38:267-271.
6. Goudie A.J., Dickins D.W., Thornton E.W. Cocaine-induced conditioned taste aversions in rats. Pharmacol Biochem Behav 1978, 8:757-761.
7. Hunt T., Amit Z. Conditioned taste aversion induced by self-administered drugs: paradox revisited. Neurosci Biobehav Rev 1987, 11:107-130.
8. Kohut S., Riley A.L. Conditioned taste aversions. Encyclopedia of psychopharmacology 2010, 336-340. Springer Verlag. I.P. Stolerman (Ed.).
9. Riley A.L., Davis C., Roma P. Strain differences in taste aversion learning: implications for animal models of drug abuse 2009, 226-261. Oxford University Press, New York, New York.
10. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987, 237:1219-1223.
11. Rocha B.A., Fumagalli F., Gainetdinov R.R., Jones S.R., Ator R., Giros B., et al. Cocaine self-administration in dopamine-transporter knockout mice. Nat Neurosci 1998, 1:132-137.
12. Sora I., Hall F.S., Andrews A.M., Itokawa M., Li X.F., Wei H.B., et al. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci U S A 2001, 98:5300-5305.
13. Chen R., Tilley M.R., Wei H., Zhou F., Zhou F.M., Ching S., et al. Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter. Proc Natl Acad Sci U S A 2006, 103:9333-9338.
14. Asin K.E., Montana W.E. Studies on D1 and D2 dopamine receptor involvement in conditioned taste aversions. Pharmacol Biochem Behav 1989, 32:1033-1041.
15. Grupp L.A. Effects of pimozide on the acquisition, maintenance, and extinction of an amphetamine-induced taste aversion. Psychopharmacology (Berl) 1977, 53:235-242.
16. Hunt T., Switzman L., Amit Z. Involvement of dopamine in the aversive stimulus properties of cocaine in rats. Pharmacol Biochem Behav 1985, 22:945-948.
17. Gale K. Catecholamine-independent behavioral and neurochemical effects of cocaine in rats. NIDA Res Monogr 1984, 54:323-332.
18. Atalay J., Wise R.A. Time course of pimozide effects on brain stimulation reward. Pharmacol Biochem Behav 1983, 18:655-658.
19. Freeman K.B., Rice K.C., Riley A.L. Assessment of monoamine transporter inhibition in the mediation of cocaine-induced conditioned taste aversion. Pharmacol Biochem Behav 2005, 82:583-589.
20. Domjan M. Effects of proximal unconditioned stimulus preexposure on ingestional aversions learned as a result of taste presentation following drug treatment. Anim Learn Behav 1978, 6:133-142.
21. Goudie A.J., Dickins D.W. Nitrous oxide-induced conditioned taste aversions in rats: the role of duration of drug exposure and its relation to the taste aversion-self-administration "paradox". Pharmacol Biochem Behav 1978, 9:587-592.
22. Goudie A.J. Conditioned food aversion: an adaptive specialisation of learning?. IRCS J Med Sci 1980, 8:591-594.
23. Foltin R.W., Preston K.L., Wagner G.C., Schuster C.R. The aversive stimulus properties of repeated infusions of cocaine. Pharmacol Biochem Behav 1981, 15:71-74.
24. Braveman N.S., Crane J. Amount consumed and the formation of conditioned taste aversions. Behav Biol 1977, 21:470-477.
25. Kalat J.W. Should taste-aversion learning experiments control duration or volume of drinking on the training day?. Learn Behav 1976, 4:96-98.
26. Bond N.W., Westbrook R. The role of amount consumed in flavor preexposure effects and neophobia. Learn Behav 1982, 10:511-515.
27. Pescatore K.A., Glowa J.R., Riley A.L. Strain differences in the acquisition of nicotine-induced conditioned taste aversion. Pharmacol Biochem Behav 2005, 82:751-757.
28. Sears L.L., Steinmetz J.E. Effects of haloperidol on sensory processing in the hippocampus during classical eyeblink conditioning. Psychopharmacology (Berl) 1997, 130:254-260.
29. Spivak K., Amit Z. The effects of pimozide on drinking behavior in the rat: an investigation using the conditioned taste aversion paradigm. Pharmacol Biochem Behav 1986, 24:1527-1531.
30. Spivak K.J., Amit Z. Effects of pimozide on appetitive behavior and locomotor activity: dissimilarity of effects when compared to extinction. Physiol Behav 1986, 36:457-463.
31. Bienkowski P., Kuca P., Piasecki J., Kostowski W. 5-HT3 receptor antagonist, tropisetron, does not influence ethanol-induced conditioned taste aversion and conditioned place aversion. Alcohol 1997, 14:63-69.
32. Fenu S., Rivas E., Di Chiara G. Differential involvement of dopamine D1 receptors in morphine- and lithium-conditioned saccharin avoidance. Physiol Behav 2009, 96:73-77.
33. Gommans J., Stolerman I.P., Shoaib M. Antagonism of the discriminative and aversive stimulus properties of nicotine in C57BL/6J mice. Neuropharmacology 2000, 39:2840-2847.
34. LeBlanc A.E., Cappell H. Antagonism of morphine-induced aversive conditioning by naloxone. Pharmacol Biochem Behav 1975, 3:185-188.
35. Freeman K.B., Verendeev A., Riley A.L. Noradrenergic antagonism enhances the conditioned aversive effects of cocaine. Pharmacol Biochem Behav 2008, 88:523-532.
36. Samaha A.N., Reckless G.E., Seeman P., Diwan M., Nobrega J.N., Kapur S. Less is more: antipsychotic drug effects are greater with transient rather than continuous delivery. Biol Psychiatry 2008, 64:145-152.
37. Seeger T.F., Thal L., Gardner E.L. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol. Psychopharmacology (Berl) 1982, 76:182-187.
38. Rebec G.V., Peirson E.E., McPherson F.A., Brugge K. Differential sensitivity to amphetamine following long-term treatment with clozapine or haloperidol. Psychopharmacology (Berl) 1982, 77:360-366.
39. LeDuc P.A., Mittleman G. Interactions between chronic haloperidol treatment and cocaine in rats: an animal model of intermittent cocaine use in neuroleptic treated populations. Psychopharmacology (Berl) 1993, 110:427-436.
40. Eibergen R.D., Carlson K.R. Behavioral evidence for dopaminergic supersensitivity following chronic treatment with methadone or chlorpromazine in the guinea pig. Psychopharmacology (Berl) 1976, 48:139-146.
41. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Dopamine receptors: from structure to function. Physiol Rev 1998, 78:189-225.
42. Vangveravong S., Taylor M., Xu J., Cui J., Calvin W., Babic S., et al. Synthesis and characterization of selective dopamine D2 receptor antagonists. 2. Azaindole, benzofuran, and benzothiophene analogs of L-741,626. Bioorg Med Chem 2010, 18:5291-5300.
43. Beninger R.J., Miller R. Dopamine D1-like receptors and reward-related incentive learning. Neurosci Biobehav Rev 1998, 22:335-345.
44. Caine S.B., Negus S.S., Mello N.K., Patel S., Bristow L., Kulagowski J., et al. Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists. J Neurosci 2002, 22:2977-2988.
45. Volkow N.D., Fowler J.S., Wang G.J., Hitzemann R., Logan J., Schlyer D.J., et al. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 1993, 14:169-177.
46. Vorel S.R., Ashby C.R., Paul M., Liu X., Hayes R., Hagan J.J., et al. Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci 2002, 22:9595.
47. Stahl S.M. Stahl's essential psychopharmacology: neuroscientific basis and practical applications 2008, Cambridge Univ Pr.
48. Cobos E.J., del Pozo E., Baeyens J.M. Irreversible blockade of sigma-1 receptors by haloperidol and its metabolites in guinea pig brain and SH-SY5Y human neuroblastoma cells. J Neurochem 2007, 102:812-825.
49. Matsumoto R.R., Pouw B. Correlation between neuroleptic binding to sigma(1) and sigma(2) receptors and acute dystonic reactions. Eur J Pharmacol 2000, 401:155-160.
50. Stone J.M., Arstad E., Erlandsson K., Waterhouse R.N., Ell P.J., Pilowsky L.S. [123I]TPCNE - a novel SPET tracer for the sigma-1 receptor: first human studies and in vivo haloperidol challenge. Synapse 2006, 60:109-117.
51. Ujike H., Kuroda S., Otsuki S. Sigma receptor antagonists block the development of sensitization to cocaine. Eur J Pharmacol 1996, 296:123-128.
52. Ritz M.C., George F.R. Cocaine toxicity: concurrent influence of dopaminergic, muscarinic and sigma receptors in mediating cocaine-induced lethality. Psychopharmacology (Berl) 1997, 129:311-321.
53. Romieu P., Phan V.L., Martin-Fardon R., Maurice T. Involvement of the sigma(1) receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade. Neuropsychopharmacology 2002, 26:444-455.
54. Levine R.R., Walsh C.T., Schwartz-Bloom R.D. Pharmacology: drug actions and reactions 2000, Parthenon Pub Group.
55. Jones J.D., Hall F.S., Uhl G.R., Riley A.L. Dopamine, norepinephrine and serotonin transporter gene deletions differentially alter cocaine-induced taste aversion. Pharmacol Biochem Behav 2010, 94:580-587.
56. Benoit Marand M., Jaber M., Gonon F. Release and elimination of dopamine in vivo in mice lacking the dopamine transporter: functional consequences. Eur J Neurosci 2000, 12:2985-2992.
57. Fabre V., Beaufour C., Evrard A., Rioux A., Hanoun N., Lesch K., et al. Altered expression and functions of serotonin 5 HT1A and 5 HT1B receptors in knock out mice lacking the 5 HT transporter. Eur J Neurosci 2000, 12:2299-2310.
58. Kim D.K., Tolliver T.J., Huang S.J., Martin B.J., Andrews A.M., Wichems C., et al. Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacology 2005, 49:798-810.
59. Riley A.L., Simpson G.R. The attenuating effects of drug preexposure on taste aversion conditioning: generality, experimental parameters, underlying mechanims, and implications for drug use and abuse. Handbook of contemporary learning theories 2001, 505-559. Lawrence Earlbaum Associates, HIllsdale, New Jersey. R.R. Mowrer, S.B. Klein (Eds.).
60. De Beun R., Rijk H.W., Broekkamp C.L. Cross-familiarisation conditioned taste aversion procedure as a method to reveal stimulus resemblance between drugs: studies on the 5-HT1A agonist 8-OHDPAT. Psychopharmacology (Berl) 1993, 112:121-128.
61. Olivier B., Gommans J., van der Gugten J., Bouwknecht J.A., Herremans A.H., Patty T., et al. Stimulus properties of the selective 5-HT reuptake inhibitor fluvoxamine in conditioned taste aversion procedures. Pharmacol Biochem Behav 1999, 64:213-220.
62. Serafine K.M., Riley A.L. Possible role of norepinephrine in cocaine-induced conditioned taste aversions. Pharmacol Biochem Behav 2009, 92:111-116.
63. Jones J.D., Hall F.S., Uhl G.R., Rice K., Riley A.L. Differential involvement of the norepinephrine, serotonin and dopamine reuptake transporter proteins in cocaine-induced taste aversion. Pharmacol Biochem Behav 2009, 93:75-81.
64. Serafine K.M., Riley A.L. Preexposure to cocaine attenuates aversions induced by both cocaine and fluoxetine: implications for the basis of cocaine-induced conditioned taste aversions. Pharmacol Biochem Behav 2010, 95:230-234.
65. Gamzu E. The multifaceted nature of taste-aversion-inducing agents: is there a single common factor?. Learning mechanisms in food selection 1977, 477-510. Baylor University Press, Waco. L.M. Barker, M.R. Best, M. Domjan (Eds.).
66. Parker L.A. Rewarding drugs produce taste avoidance, but not taste aversion. Neurosci Biobehav Rev 1995, 19:143-157.
67. Riley A.L. The paradox of drug taking: the role of the aversive effects of drugs. Physiol Behav 2011, 103:69-78.
68. Grigson P.S. Conditioned taste aversions and drugs of abuse: a reinterpretation. Behav Neurosci 1997, 111:129-136.
69. Parker L.A., Limebeer C.L., Shadna A.R. Conditioned disgust, but not conditioned taste avoidance, may reflect conditioned nausea in rats. Conditioned taste aversion: behavioral and neural processes 2009, 92-113. Oxford University Press, New York, New York. S. Reilly, T. Schachtman (Eds.).
70. Cunningham C.L., Gremel C.M., Groblewski P.A. Genetic influences on conditioned taste aversion 2009, 387-421. Oxford University Press, New York, New York. S. Reilly, T. Schachtman (Eds.).
71. Sorge R.E., Fudge M.A., Parker L.A. Effect of sodium deprivation on morphine-and lithium-induced conditioned salt avoidance and taste reactivity. Psychopharmacology (Berl) 2002, 160:84-91.
72. Verendeev A., Riley A.L. Relationship between the rewarding and aversive effects of morphine and amphetamine in individual subjects. Learn Behav 2011.
73. Turenne S.D., Miles C., Parker L.A., Siegel S. Individual differences in reactivity to the rewarding/aversive properties of drugs: assessment by taste and place conditioning. Pharmacol Biochem Behav 1996, 53:511-516.